Skip to main content
Advertisement
The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study

January 20, 2026

The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study

Ayaka Monoi and colleagues model the benefits and risks of maternal RSV vaccination by gestational age and show that benefits outweigh risks with vaccination from the third trimester.

Image credit: National Institute of Allergy and Infectious Diseases, Unsplash

01/12/2026

Research Article

Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage

Thomas Stanton and colleagues use whole genome sequencing to evaluate the prevalence of Klebsiella pneumoniae K and O antigen types in 13 countries in Africa and South Asia to help inform vaccine design against neonatal sepsis.

Image credit: National Institute of Allergy and Infectious Diseases, Unsplash

Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage

Recently Published Articles

Current Issue

Browse Issues 2004 – 2025

01/29/2026

Editorial

Intervention research to protect human health in the era of climate extremes

In this Editorial, PLOS Medicine Editor-in-Chief Till Bärnighausen and Executive Editor Helen Lumbard outline how climate change and associated extreme weather events are threatening human health, and call for research on the effectiveness of climate adaptation interventions.

Image credit: Chamika Jayasri, Unsplash

Intervention research to protect human health in the era of climate extremes

Get new content from PLOS Medicine in your inbox

PLOS Medicine | ISSN: 1549-1676 (online)